Bio-Techne Corp. (TECH)
72.58
+0.18
(+0.25%)
USD |
NASDAQ |
Oct 05, 16:00
72.59
+0.01
(+0.01%)
Pre-Market: 20:00
Bio-Techne Max Drawdown (5Y) : 67.22% for Sept. 30, 2026
Max Drawdown (5Y) Chart
Historical Max Drawdown (5Y) Data
| Date | Value |
|---|---|
| September 30, 2026 | 67.22% |
| August 31, 2026 | 67.22% |
| July 31, 2026 | 67.22% |
| June 30, 2026 | 67.22% |
| May 31, 2026 | 67.22% |
| April 30, 2026 | 64.82% |
| March 31, 2026 | 64.82% |
| February 28, 2026 | 64.82% |
| January 31, 2026 | 64.82% |
| December 31, 2025 | 64.82% |
| November 30, 2025 | 64.82% |
| October 31, 2025 | 64.82% |
| September 30, 2025 | 64.82% |
| August 31, 2025 | 64.82% |
| July 31, 2025 | 64.82% |
| June 30, 2025 | 64.82% |
| May 31, 2025 | 64.82% |
| April 30, 2025 | 64.24% |
| March 31, 2025 | 60.51% |
| February 28, 2025 | 60.51% |
| January 31, 2025 | 60.51% |
| December 31, 2024 | 60.51% |
| November 30, 2024 | 60.51% |
| October 31, 2024 | 60.51% |
| September 30, 2024 | 60.51% |
| Date | Value |
|---|---|
| August 31, 2024 | 60.51% |
| July 31, 2024 | 60.51% |
| June 30, 2024 | 60.51% |
| May 31, 2024 | 60.51% |
| April 30, 2024 | 60.51% |
| March 31, 2024 | 60.51% |
| February 29, 2024 | 60.51% |
| January 31, 2024 | 60.51% |
| December 31, 2023 | 60.51% |
| November 30, 2023 | 60.51% |
| October 31, 2023 | 59.16% |
| September 30, 2023 | 49.53% |
| August 31, 2023 | 47.51% |
| July 31, 2023 | 47.51% |
| June 30, 2023 | 47.51% |
| May 31, 2023 | 47.51% |
| April 30, 2023 | 47.51% |
| March 31, 2023 | 47.51% |
| February 28, 2023 | 47.51% |
| January 31, 2023 | 47.51% |
| December 31, 2022 | 47.51% |
| November 30, 2022 | 47.51% |
| October 31, 2022 | 47.51% |
| September 30, 2022 | 47.41% |
| August 31, 2022 | 39.99% |
Max Drawdown Definition
Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.
Max Drawdown (5Y) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Max Drawdown (5Y) Benchmarks
| Repligen Corp. | 68.27% |
| BioLife Solutions, Inc. | 85.14% |
| MindWalk Holdings Corp. | 98.24% |
| Maravai Lifesciences Holdings, Inc. | 97.16% |
| MaxCyte, Inc. | 96.07% |
Max Drawdown (5Y) Related Metrics
| Alpha (5Y) | -26.13 |
| Beta (5Y) | 1.298 |
| Annualized Standard Deviation of Monthly Returns (5Y Lookback) | 38.38% |
| Historical Sharpe Ratio (5Y) | -0.3424 |
| Historical Sortino (5Y) | -0.6744 |
| Monthly Value at Risk (VaR) 5% (5Y Lookback) | 16.03% |